Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -372,177 | -444,037 | -395,893 | -342,252 | -259,581 |
| Depreciation Amortization | 33,345 | 29,522 | 21,609 | 19,993 | 3,005 |
| Income taxes - deferred | -2,828 | -3,479 | N/A | N/A | N/A |
| Accounts receivable | -69,189 | -149 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -7,841 | 4,828 | 5,883 | 6,976 | -2,964 |
| Other Working Capital | -122,556 | -6,521 | -2,892 | 24,553 | 2,983 |
| Other Operating Activity | 188,269 | 58,016 | 78,536 | 62,789 | 51,423 |
| Operating Cash Flow | $-352,977 | $-361,820 | $-292,757 | $-227,941 | $-205,134 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,769 | 79,681 | 276,880 | 37,706 | -271,062 |
| PPE Investments | -11,069 | -22,290 | -20,425 | -37,574 | -46,791 |
| Net Acquisitions | -52,573 | -212,633 | N/A | N/A | N/A |
| Investing Cash Flow | $-96,411 | $-155,242 | $256,455 | $132 | $-317,853 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,000 | N/A |
| Common Stock Issued | 403,522 | 465,754 | 192,799 | 238,268 | 9,663 |
| Other Financing Activity | -12,858 | -2,795 | -2,649 | 0 | 566,759 |
| Financing Cash Flow | $390,664 | $462,959 | $190,150 | $239,268 | $576,422 |
| Exchange Rate Effect | -541 | -2,740 | N/A | N/A | N/A |
| Beginning Cash Position | 181,318 | 238,161 | 84,313 | 72,854 | 19,419 |
| End Cash Position | 122,053 | 181,318 | 238,161 | 84,313 | 72,854 |
| Net Cash Flow | $-59,265 | $-56,843 | $153,848 | $11,459 | $53,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | -352,977 | -361,820 | -292,757 | -227,941 | -205,134 |
| Capital Expenditure | -11,069 | -22,290 | -20,425 | -37,574 | -46,791 |
| Free Cash Flow | -364,046 | -384,110 | -313,182 | -265,515 | -251,925 |